Lesley G. Mitchell, MD

Professor
University of Alberta, Division of Pediatric Hematology/Oncology

Presentation(s):

• SS 03.3 - Anticoagulant Effects of DOACs in Children: Coagulation Assay Responses

  Saturday, July 9, 2022
  12:05 PM – 12:25 PM

• OC 15.1 - PREVAPIX-ALL: Phase 3 Study of the Safety and Efficacy of Apixaban for Thromboprophylaxis versus Standard of Care in Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia or Lymphoma (ALL/LL)

  Sunday, July 10, 2022
  10:45 AM – 11:00 AM

• PB0254 - Effects of apixaban versus vitamin K antagonists and low molecular weight heparin in pediatric cardiac patients: exploratory biomarker analysis from SAXOPHONE a multicentre randomized clinical trial

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM